Targeting insulin resistance after stroke cuts cardiovascular risk
Large trial shows pioglitazone could reduce risk of cardiovascular events or diabetes in stroke patients
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research
More News: Actos | Cardiology | Cardiovascular | Diabetes | Drugs & Pharmacology | Endocrinology | Heart | Insulin | Stroke